Kyle Faget Discusses Regulating Software as a Medical Device on MedTech Connect Podcast
January 6, 2023
Medtech Insight
Foley & Lardner LLP Partner Kyle Faget is interviewed in the first episode of MedTech Connect, a new digital health podcast series by Medtech Insight, about the complexities behind regulating software as a medical device (SaMD).
In the episode, “How Do We Regulate Software as a Medical Device?” Faget offers valuable insight on the regulatory landscape of SaMD, and provides clarity for businesses that might be unsure if their software is even regulated by the U.S. Food and Drug Administration, let alone understand how to go about the clearance process.
Listen to the episode on Apple Podcasts, SoundCloud, and Spotify.
(Subscription required)
People
Related News
June 10, 2025
In the News
Lynn Gandhi Sheds Light on Supreme Court Tax Ruling
Foley partner Lynn Gandhi commented in the Bloomberg Tax article "High Court’s Catholic Charities Case to Go Beyond Unemployment," sharing insight on the implications of the recent Supreme Court ruling in a tax case.
June 10, 2025
In the News
James McFall Joins Iconic Athletes and Leaders in Launch of Stanford Football Alumni United
Foley & Lardner LLP is proud to announce that partner James Carlos McFall is a founding member of Stanford Football Alumni United (SFAU), a newly formed coalition of former players and leaders committed to supporting Stanford Football’s continued growth and national competitiveness.
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."